First drug for delusions in Parkinson's patients approved

May 2, 2016 11:55 AM

28 0

First drug for delusions in Parkinson's patients approved

Federal health officials have approved an experimental drug to treat psychotic delusions and behaviors that often afflict patients with Parkinson's disease, the debilitating movement disorder.

The drug from Acadia Pharmaceuticals Inc. is the first drug for the condition, which affects approximately half of Parkinson's patients. An estimated 50,000 Americans are diagnosed with Parkinson's each year, making it the second-most common neurodegenerative disease in the U.S.

Read more

To category page

Loading...